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Background: To retrospectively compare axial elongation in children with different degrees of myopia wearing
spectacles and undergoing ortho-k treatment.
Methods: The medical records of 128 patients who were fitted with spectacles or orthokeratology (ortho-k) lenses
in our clinic between 2008 and 2009 were reviewed. Ortho-k group comprised 65 subjects and 63 subjects wearing
spectacles were included in the control group. Subjects were also divided into low-myopia, moderate-myopia and
high-myopia groups, based on the basic spherical equivalent refractive error. Axial length periodically measured
over 2-year of lens wear and changes in axial length were compared between treatment groups and between
subgroups with different degrees of myopia.
Results: The control group exhibited more changes in axial length than the ortho-k group at both 12 months
(0.39 ± 0.21 mm vs 0.16 ± 0.17 mm, p <0.001) and 24 months (0.70 ± 0.35 mm vs 0.34 ± 0.29 mm, p <0.001). Axial
length elongation was estimated to be slower by about 51% in the ortho-k group. Similar results were found for
the subgroups (49%, 59% and 46% reductions, respectively). In the group with low and moderate myopia, the
annual increases in axial length were significantly different between the ortho-k and control groups during both
the first ( Low myopia: 0.19 ± 0.17 mm vs 0.40 ± 0.18 mm, p = 0.001; Moderate myopia: 0.14 ± 0.18 mm vs 0.45 ± 0.22 mm,
p <0.001) and second ( Low myopia: 0.18 ± 0.14 mm vs 0.32 ± 0.19 mm, p = 0.012; Moderate myopia: 0.18 ± 0.16 mm vs
0.34 ± 0.30 mm, p = 0.030) years. In the high myopia groups, significant differences were only found between the ortho-k
and control groups during the first year (0.16 ± 0.18 mm vs 0.34 ± 0.22 mm, p = 0.004). The 2-year axial elongation was
significantly associated with initial age (p <0.001) and treatment (p <0.001), but not with gender, initial refractive error,
initial axial length, initial corneal curvature.
Conclusions: This 2-year study indicates that ortho-k contact lens wear is effective for reducing myopia progression in
children with low, moderate and high myopia.
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Myopia is one of the most common ocular disorders and
has become more prevalent in both adults and children
[1,2]. High myopia is associated with increased risks of
retinal and vitreous detachments as well as other disor-
ders, such as glaucoma and macular degeneration. High
myopia is also associated with increased healthcare costs
and ocular-related morbidity [3]. Therefore, many methods* Correspondence: jfzhu1974@hotmail.com
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unless otherwise stated.have been implemented to try to slow or stop the develop-
ment of myopia in children [4]. These methods generally
fall into two major categories: the topical application of
tropicamide [5], atropine [6], pirenzepine [7] or some
ocular hypotensive agent [8] or optical treatments, such
as rigid contact lenses [9], bifocal spectacle lenses [10]
or multifocal spectacle lenses [11]. However, none of these
methods are ideal due to limitations in efficacy, safety,
economic feasibility or ease of application.
Myopia is a remediable cause of visual impairment [12]
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launched by the World Health Organization (WHO) [13].
Vision 2020 also seeks to increase awareness of the grow-
ing problem of myopia in children. Although the impact
of myopia on quality of life is not as large as the impact
from cataracts or other ocular pathologies [14], the age of
onset for refractive errors suggests that this burden may
be, in some ways, even greater than that of cataracts [15].
If effective treatment strategies can be found to reduce the
rate of myopic progression, effects on socioeconomic
health caused by myopia, can be profoundly reduced.
The specific mechanisms involved in the etiology of
myopia are still unclear; however, there are currently
three hypotheses regarding the progression of juvenile-
onset myopia. First, it has been hypothesized that a high
near-accommodation lag induces abnormal axial growth
of the eye [16], though many studies have found no associ-
ation between accommodative lag and myopic progression
[17,18]. The second hypothesis is based on longitudinal
ocular growth data from emmetropic and myopic children
and states that mechanical tension, created by the crys-
talline lens or ciliary body, restricts equatorial ocular ex-
pansion and causes accelerated axial elongation [19]. A
thickened ciliary muscle [20] and thinned crystalline lens
[21] play important roles in maintaining proportional ex-
pansion of the globe during eye growth and accelerated
axial growth results [22] when the crystalline lens can no
longer decrease in power by thinning and stretching [19].
The third hypothesis proposes that myopic eyes are rela-
tively more hyperopic from the peripheral retina to the
fovea so that when there are conflicting visual signals in
the central and peripheral retina, the peripheral retinal
signals dominate axial growth and central refractive devel-
opment [22]. Longitudinal data, obtained two years prior
to the onset of myopia in children who ultimately become
myopic, has demonstrated a significant increase in relative
peripheral hyperopia, and a relatively more prolate shape
[19]. However, this hypothesis remains controversial [23].
Clinicians have been searching for treatments to control
the progression of myopia based on these hypotheses;
however, few studies have shown clinically significant
results.
Orthokeratology (ortho-k) is defined as the clinical
technique that uses specially designed and fitted rigid
contact lenses to reshape the corneal contour to tempor-
arily modify or eliminate refractive error. It was first in-
troduced in the early 1960 s [24], but safety concerns
and outcome unpredictability limited its use [25]. Since
the mid-1990s, the acceptance of ortho-k has signifi-
cantly increased, mainly due to huge technological de-
velopments in the field of contact lenses, such as the
availability of highly-permeable materials [26] and the
advent of advanced digital processing technology which
uses computer assisted system to achieve optimal lensfitting [27]. A number of recent reports have demon-
strated “overnight ortho-k” to be effective for controlling
the progression of myopia [28-35]. In fact, several previ-
ous studies have reported the efficacy of ortho-k use in
those with low to moderate myopia [28-32]; however,
few studies have directly examined the effects of spherical,
reverse geometry ortho-k lens designs on axial length
elongation in highly myopic children [35,36]. The pur-
pose of the current study was to assess the effectiveness
of ortho-k contact lenses in Chinese myopic children
with different degrees of myopia over 24 months.
Methods
Subjects
The medical records of children who came to our clinic for
vision correction using spectacles or ortho-k were reviewed
and pertinent data was retrieved. A total of 128 files were
included, 65 ortho-k treated subjects (ortho-k group) and
63 spectacle-wearing subjects (control group). Each group
was designed to achieve 90% power to detect a minimum
0.18 mm (about 0.50D) difference in axial elongation in
two years at the 5% level of statistical significance, using
group standard deviation of 0.27 mm based on previous
studies [28]. The minimal required sample size was calcu-
lated to be 49. Each group was further divided into three
sub-groups based on the basic spherical equivalent refract-
ive error (SER): low-myopia (−3.00D < SER < −0.50D),
moderate-myopia (−6.00D < SER ≤ −3.0D) and high-
myopia (SER ≤ −6.0D). The ortho-k group selection
was based on the inclusion criteria listed in Table 1.
The medical records of all ortho-k patients seen in our
hospital from January 2008 to February 2009 were ex-
amined and those that met the inclusion criteria were
sorted out. About twenty subjects were then randomly
selected for inclusion in each sub-group, according to
basic SER. For the control group, we chose all out-
patient refractive files that matched inclusion criteria
during the same time period as ortho-k patients; about
20 control subjects were randomly selected for each
sub-group.
The current investigation followed the tenets of the
Declaration of Helsinki and was approved by the Ethical
Committee of the Shanghai Eye Disease Prevention and
Treatment Center. All subjects, and their parents, pro-
vided signed written informed consent for treatment and
were fully informed of the risks and benefits of the
treatment.
Materials
The lenses used in ortho-k group, Euclid overnight
ortho-k lenses (Euclid Systems Corporation, Herndon,
USA), were made of Boston EQUALENS II (oprifocon
A) with an oxygen permeability coefficient of 85 × 10−11
(cm2 • ml02) / (s•ml•mmHg), a diameter of 10.6 mm, an
Table 1 Inclusion criteria
Age Subjects were 7–14 years of age
Visual acuity Had no other ocular diseases aside from refractive error and no keratoconus (confirmed by pre-treatment corneal topography)
Refractive errors Had an intraocular pressure (IOP) of <21 mmHg
Ocular health Had an with-the- rule astigmatism (axes 180 ± 30)≤ 1.50 D
Had a BCVA (best corrected visual acuity) ≤0.00 log MAR units in both eyes (Snellen equivalent to 20/20)
Had no binocular vision problems
Others No medications that might affect refractive development
Had no history of ortho-k or contact lens wear
Maintained regularly scheduled visits and completed the 2-year follow-up
Had no significant deviations during lens wear (criteria only for ortho-k group)
Discontinued lens wear a total of 30 days or less during the 2 years (criteria only for ortho-k group)
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of 36° and a four anti-arc inner surface geometry.
Appropriate trial lenses were chosen according to cor-
neal curvature and other parameters (refractive error,
corneal diameter). The subjects then tried the lenses for
30 minutes. Fluorescein pattern was used to observe the
lens fit in each eye under slit lamp, before the final base
and alignment curve of the lens was chosen. Ideal lenses
had a good central position, a 0.5-1.0 mm range of move-
ment, a 3.0-4.0 mm flat contact area in the center of the
cornea, a 1.0-2.0 mm annulus of tear reservoir in the
reverse curve, a parallel curve with the cornea and a
0.5-1.0 mm area of annulus of tear reservoir in the periph-
eral curve. Final lenses were determined after optimization
and were worn overnight for ≥7 hours. The subjects were
provided with clear instructions regarding the wearing
and maintenance of lenses. Follow-up appointments were
promptly planned (see Return visits).
Although the ortho-k lens design used in this study
was recommended for myopia reduction not more than
6.00 D, we also used this design for subjects with high
myopia. The main objective of ortho-k treatment was to
slow myopic progression. If the subject’s refractive error
was beyond the limit of correction range of ortho-k lens,
a maximum manufacturer’s recommended diopter cor-
rection lens was prescribed under the corneal parame-
ters condition. A subjective refraction was conducted in
subjects, after 1 month of wearing the ortho-k lenses, to
obtain the residual refraction error. Taking into account
the further declining of myopia , pair of spectacles that
we prescribed for subjects were 0.5D lower than the re-
sults of subjective refraction (residual refractive error
greater than 0.50 D) to meet the needs of daily life of
subjects temporary. A subjective refraction was again
conducted after subjects had worn ortho-k lenses for
3 months and spectacles were prescribed according to
the results of subjective refraction results. Thus, if full
reduction in any degree of myopia was not achieved (re-
sidual refractive error greater than 0.50 D), the subjectswere required to wear spectacles during the day. Spec-
tacle prescription would be updated at any subsequent
visit if diffierence in residual refractive error obtained at
that visit exceeded 0.50D.
The control group wore single-vision spectacles. The
lenses were modified according to visual acuity and re-
fractive changes where appropriate throughout the study.
Measurement techniques
Standard subjective refraction techniques were used to
determine accurate refractive error. A pentacam (Oculus,
Wetzlar, Germany) was used to monitor changes in cor-
neal topography. Slit lamp biomicroscopy was used to
monitor corneal health and integrity at each measurement
session. Corneal integrity was assessed with topical appli-
cation of sodium fluorescein dye. The axial length was
evaluated using an IOLMaster (Carl Zeiss Jena GmbH,
Jena, Germany). Three measurements were taken at each
visit and the average of the 3 was used as a representative
value.
Return visits
For all subjects (both ortho-k and control groups), cyclo-
plegic refraction was performed at the first visit. Non-
cycloplegic refraction was also performed the following
day. In the follow up visit, only non-cycloplegic subject-
ive refraction were conducted. Subjects in the ortho-k
group were examined 1, 7, 30 and 90 days after begin-
ning ortho-k treatment. After the initial 90 days, subjects
were examined every 3 months. Corneal integrity, cor-
neal topography, visual acuity, refraction and IOP mea-
surements were performed every 3 months and axial
length was measured every 6 months. Subjects were also
examined whenever an abnormal symptom occurred. If
corneal staining was observed, ortho-k lens wear were
asked to be ceased for 2 days for low level staining
(grade 1, Efron Grading Scale), and 5 ~ 7 days for more
intense staining (grade 2 and grade 3, Efron Grading
Scale) first.Then subjects should return for examination
Table 2 Baseline demographics and biometric data of
subjects enrolled in the study
Ortho-k Control P value
Total N = 65 N = 63
Age (y) 9.82 ± 1.63 9.86 ± 2.12 0.923*
M/F ratio 23:42 26:37 0.134†
SER (D) −4.29 ± 2.04 −4.24 ± 2.38 0.898*
Corneal curvature (D) 43.45 ± 1.27 43.45 ± 1.47 0.999*
Axial length (mm) 24.91 ± 0.83 24.85 ± 1.08 0.725*
Low myopia N = 20 N = 20
Age (y) 9.23 ± 1.53 8.87 ± 1.71 0.481*
M/F ratio 7:13 8:12 0.744†
SER (D) −1.99 ± 0.56 −1.64 ± 0.62 0.074*
Corneal curvature (D) 43.07 ± 1.54 43.41 ± 1.71 0.521*
Axial length (mm) 24.29 ± 0.73 23.97 ± 0.87 0.207*
Moderate myopia N = 23 N = 21
Age (y) 9.72 ± 1.22 10.16 ± 1.82 0.358*
M/F ratio 9:14 9:12 0.802†
SER (D) −3.97 ± 0.77 −3.82 ± 0.53 0.439*
Corneal curvature (D) 43.45 ± 1.02 43.56 ± 1.41 0.765*
Axial length (mm) 24.78 ± 0.40 24.74 ± 0.83 0.829*
High myopia N = 22 N = 22
Age (y) 10.48 ± 1.92 10.47 ± 2.46 0.995*
M/F ratio 7:15 9:13 0.531†
SER (D) −6.72 ± 0.62 −7.01 ± 1.18 0.316*
Corneal curvature (D) 43.79 ± 1.19 43.39 ± 1.33 0.290*
Axial length (mm) 25.61 ± 0.73 25.77 ± 0.70 0.477*
*Unpaired t-test.
†Chi-square test.
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their corneal were completed recovered.Data collection
was resumed after a few days resuming lens wear as ne-
cessary. All examinations were performed within 2 hours
of removing the lens (between 8 and 10 o’clock in the
morning). In the control group, axial length, refraction
and visual acuity were measured and these examinations
were performed every 6 months until the end of the 2-year
study period.
Data analysis
Since all data were distributed normally (Kolmogorov-
Smirnov test, P >0.05), parametric tests were used for
data analysis. Unpaired t tests were used to compare the
baseline data and Chi-square tests were used to compare
the difference in the male/female ratio (M/F ratio) between
the two groups of subjects. To determine myopic progres-
sion, repeated measures analysis of variance (ANOVAs)
were used to compare the change in axial length over time
in the two groups. If significant differences were found,
paired t tests with Bonferroni correction were performed
to compare the differences in axial length. An unpaired
t-test was used to compare the annual increases in axial
length between the two study groups during the 2-year
treatment period. Factors affecting axial elongation, in-
cluding age, gender, treatment, initial spherical equivalent
refractive error and initial corneal curvature were exam-
ined using stepwise multiple linear regression analysis.
Data analysis was performed in SPSS statistical software
program (SPSS software ver. 16.0; SPSS Inc., Chicago,
IL, USA). The level of statistical significance was set at
5%. Only data from the right eyes of the subjects were
analyzed.
Results
Ortho-k group comprised 65 subjects (23 boys and 42
girls), ranging in age from 7 to 14 years. The SER
ranged from −1.25 to −2.75 D in the low myopia group,
from −3.25 to −5.50 D in the moderate myopia group
and from −6.00 to −7.88 D in the high myopia group
(Table 2).
Spectacle control group comprised 63 subjects (26
boys and 37 girls), ranging in age from 7 to 14 years. In
this group, the SER ranged from −1.00 to −2.75 D in the
low myopia control group, from −3.13 to −4.75 D in
moderate myopia control group and from −6.00 to
−10.13 D in the high myopia control group (Table 2).
There were no statistically significant differences in
baseline values between the ortho-k and spectacle con-
trol groups in terms of age, gender distribution, SER,
corneal curvature, axial length (P >0.05, unpaired t-test
and Chi-square test, Table 2). Baseline characteristics of
the different degrees of myopia were also balanced be-
tween the two groups (Table 2).The mean (±SD) SER and axial length of the Ortho-k
and spectacle subgroups are listed in Table 3. The SER
changed significantly after 2-year treatment in different
degree of myopia for both group (p <0.001, repeated-
measures ANOVA). There was also a significant elongation
in axial length in both the ortho-k and spectacle control
groups over the time course of the study (p < 0.001,
repeated-measures ANOVA). During the 2 year period,
the spectacle control group exhibited more change in
axial length than did the ortho-k group during both the
first year (0.39 ± 0.21 mm vs 0.16 ± 0.17 mm,; 59% slower
in the ortho-k group) and the second year (0.31 ± 0.24 mm
vs 0.18 ± 0.15 mm,; 42% slower in the ortho-k group). In
total, the increase in axial elongation was 51% slower in
the ortho-k group (0.70 ± 0.35 mm in control group vs
0.34 ± 0.29 mm in ortho-k group) at the end of the 24-
month study period. Similar results were found in the
subgroups. There was a significant difference in axial
elongation when comparing ortho-k and control groups
Table 3 Mean (±SD) spherical equivalent refractive error
and axial length in different degree of myopia for the
ortho-k and spectacle groups during the study period
1 year 2 year
Axial length
Low myopia
Ortho-k 24.48 ± 0.75 24.67 ± 0.74
Control 24.36 ± 0.88 24.69 ± 0.81
Moderate myopia
Ortho-k 24.92 ± 0.35 25.11 ± 0.37
Control 25.19 ± 0.79 25.53 ± 0.76
High myopia
Ortho-k 25.77 ± 0.78 25.95 ± 0.89
Control 26.11 ± 0.70 26.38 ± 0.70
Total
Ortho-k 25.07 ± 0.82 25.26 ± 0.87
Control 25.25 ± 1.06 25.56 ± 1.02
spherical equivalent refractive error (SER)
Low myopia
Ortho-k 0.00 ± 0.24 −0.22 ± 0.24
Control −2.09 ± 0.43 −2.73 ± 0.77
Moderate myopia
Ortho-k −0.36 ± 0.45 −0.71 ± 0.45
Control −4.52 ± 0.86 −5.06 ± 0.98
High myopia
Ortho-k −1.97 ± 1.30 −2.17 ± 1.30
Control −7.59 ± 1.34 −8.19 ± 1.39
Total
Ortho-k −0.80 ± 1.18 −1.05 ± 1.15
Control −5.02 ± 2.34 −5.60 ± 2.38
Figure 1 Axial elongation (mm) over the 2-year treatment period in s
spectacle groups.
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the second year. When comparing the ortho-k and spec-
tacle control groups with high myopia, the difference in
axial elongation was only found during the first year, but
not during the second year. At the end of the 2-year study,
significant differences in total axial elongation were found
for all degrees of myopia. The elongation of axial length
was 49%, 59%, and 46% slower for the low, moderate and
high myopia subgroups, respectively (53%, 69%, and 53%
slower during the first year and 44%, 47%, and 33% slower
during the second year) (Figure 1, Table 4).
The regression of the model using treatment and initial
age to predict axial elongation was fair (adjusted R2 = 0.41)
and significant (p <0.001). Hence, linear regression of axial
elongation and initial age was performed for each group.
Figure 2 shows the axial elongation plotted against the ini-
tial ages during the 2-year period for both groups. The
linear regression equation is y = −0.05x + 0.83 (R2 = 0.08,
p = 0.023) for the ortho-k group and y = −0.10x + 1.67
(R2 = 0.35, p < 0.001) for the control group.
The mean age of all subjects (9.84 ± 1.88 years) was se-
lected as the cutoff value and subjects were divided into
two age groups. Subjects ranging in age from 7 to 9.8 years
were considered to be the younger group, whereas sub-
jects older than 9.9 years of age were considered to be the
older group. As shown in Figure 3, axial elongation was
nearly 61% slower in the ortho-k subjects compared with
the control subjects in the younger group after 2 years. In
the older group, axial elongation was only 35% slower in
ortho-k versus control subjects.
During the 2-year study period, corneal staining (grade
1 ~ grade 3, Efron Grading Scale) was found in 17 ortho-
k subjects. Through clinical examination, all subjects
completely recovered after discontinuation of lens wear
for 2–14 days. There were no adverse events reported in
the spectacle group.ubjects with different degrees of myopia in the ortho-k and
Table 4 Changes in axial length during the 2-year
treatment of subjects with different degrees of myopia
between the ortho-k group (65 subjects) and spectacle
group (63 subjects)
First year Second year 2 years
Low myopia
Ortho-k 0.19 ± 0.17 0.18 ± 0.14 0.37 ± 0.28
Control 0.40 ± 0.18 0.32 ± 0.19 0.72 ± 0.28
t −3.80 −2.64 −3.97
P 0.001 0.012 <0.001
Moderate myopia
Ortho-k 0.14 ± 0.18 0.18 ± 0.16 0.32 ± 0.31
Control 0.45 ± 0.22 0.34 ± 0.30 0.79 ± 0.39
t −5.09 −2.24 −4.40
P <0.001 0.030 <0.001
High myopia
Ortho-k 0.16 ± 0.18 0.18 ± 0.15 0.33 ± 0.30
Control 0.34 ± 0.22 0.27 ± 0.21 0.61 ± 0.36
t −3.05 −1.651 −2.814
P 0.004 0.107 0.007
Total
Ortho-k 0.16 ± 0.17 0.18 ± 0.15 0.34 ± 0.29
Control 0.39 ± 0.21 0.31 ± 0.24 0.70 ± 0.35
t −6.87 −3.699 −6.408
P <0.001 <0.001 <0.001
Figure 2 Scatterplots showing correlations of axial growth at the 24-m
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The data from the current study support the theory that
ortho-k can reduce progression of myopia by approxi-
mately half compared with traditional spectacle lenses.
The major strength of the current study is the inclusion
of a greater number of subjects with moderate and high
myopia compared to previous studies [30-32], which
allowed the effectiveness of ortho-k lens to be evalu-
ated in those with different degrees of myopia.
Cho et al. [28] first reported that an increase in axial
length of 0.29 mm in an ortho-k-treated group and of
0.54 mm in a spectacle group over a 2-year period. Since
then, similar results have been obtained in several other
studies [29-33]. Walline et al. [30] reported that the in-
crease in axial length after 2 years was 0.25 mm in an
ortho-k group and 0.57 mm in a control group. Kakita et
al. [29] and Santodomingo-Rubido et al. [32] also reported
differences in axial length increases between myopic chil-
dren wearing ortho-k contact lenses and those wearing
single-vision spectacles (0.39 mm vs 0.61 mm and
0.47 mm vs 0.69 mm, respectively), over a 2-year period.
In a randomised study, Cho and Cheung [34] reported
slower axial elongation of 43% in low myopes. Chen
et al. [33] reported 52% slower increase in axial length
with toric ortho-k. The change in axial length growth
between the ortho-k and spectacle groups found in our
study is reasonably consistent with previously reported
studies, although variations in ethnicity, age and basic
refractive error between studies likely affect the rates of
myopic progression [28-34].ƽOrtho- k
y= - 0 . 05x+ 0 . 83
R 2= 0 . 08
○Control
y= - 0 . 10x+ 1 . 67
R 2= 0 . 35
onth visit with baseline age in ortho-k and control groups.
Figure 3 Changes in axial length in younger (age below average)
and older (age above average) children in the ortho-k and control
groups after 2-year monitoring.
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among Chinese adults (greater than 30 years of age) has
been reported to be 2% to 5% [37,38], whereas the
prevalence of high myopia (greater than −6.00 D)
among Chinese children, aged 5 to 16, has been reported
to be approximately 1.19% [39]. Pathologic complications,
poor vision quality and decreased quality of life are all as-
sociated with high myopia. Controlling the rate of myopic
progression, thereby reducing the prevalence of high my-
opia, may result in fewer pathologic complications and
improved quality of life [40]. Since children with severe
myopia have faster myopic progression [39] in general, it
is logical that they would benefit most from a treatment
that retards myopic progression. However, information
about treatments for high myopia is rare since most stud-
ies examining treatments for myopia had been performed
in children with low to moderate myopia. In a small study,
involving 20 highly myopic children (greater than −6.00
D), myopic progression was found to be significantly re-
duced after treatment with 0.5% atropine eye drops [41].
A subsequent case–control study indicated that 1% topical
atropine was effective in slowing myopic progression in
moderately to severely myopic children (initial refractive
errors: −5.18 ± 2.05 D) at the end of 1 year of treatment
[42]. Chen, Cheung and Cho [43] reported no significant
increase in axial length of two highly myopic, astigmatic
subjects, with histories of myopic progression after they
were treated with toric, ortho-k lenses. A recent random-
ized study showed that ortho-k lenses effectively slowed
myopic progression in high myopes. In that study, which
axial length elongation was reported to be 63% slower in
children treated with partial correction ortho-k lenses
compared to children wearing spectacles [35]. In thecurrent study axial length elongation was found to be
46% slower in the high myopic ortho-k group com-
pared with the spectacle group. Although full reduc-
tion was not achieved in the current study with current
ortho-k lens designs, ortho-k was shown to be effective
to slow myopic progression during the 24-month period
of lens wear in subjects with low, moderate and high my-
opia. Previous studies have reported that subjects with
higher baseline SERs benefited the most from ortho-k
treatment [29,30]. However, in this study, subjects with all
degrees of myopia demonstrated similar therapeutic bene-
fits from ortho-k, specifically in retarding axial growth.
The results of the current study are in agreement with
previous studies in that there is a significant negative
correlation between initial age and the change in axial
length after 24 months of ortho-k treatment. This result
is supported by observations in 3 other recent studies
[31,33,34]. Hence, we concurred with Cho and Cheung
[34] that younger myopic children will benefit more
from ortho-k treatment than older myopic children. The
annual axial elongation in the current study in high my-
opia group was 0.16 and 0.18 mm in the first and second
years, respectively, in the ortho-k subjects, and was 0.34
and 0.27 mm, respectively, in the control subjects. Our
results had little difference with the annual growth in
the first year as reported by Charm J and Cho P [35],
whose results showed relatively better myopic control in
the first year of the study period (80% slower) compared
with the second year (38% slower), while the value in
current study was only 53% in the first year and 33% in
the second year. This difference may be due to the dif-
ferent inclusion criteria in age of the two studies (8–11
years of age in Charm J and Cho P’s study and 7–14
years of age in our study). But the tendency of reduced
myopic control effect in high myopia was same and
this phenomena was also occurred in low and moder-
ate myopia in current study. This may be due to the
slowing of myopic progression in the control group
[31,35]. Another explanation may be the adaptation of
subjects to the signal that slows myopic progression in
the ortho-k group [34]. However, information on the
effectiveness of ortho-k was only available over a 2-year
period. It remains to be seen whether ortho-k lenses
should be worn continually, what treatment duration will
optimize the reduction in myopic progression. Further
studies are needed to address these questions.
One limitation of this study is that this was a retrospect-
ive study. Factors may affect myopic progression, such as
peripheral refractive status, accommodative lag, pupil size,
retinal image quality, a history of parental myopia, were
not recorded in either group. A second potential limita-
tion is that, although there were already some articles
about the short-term changes in ocular biometry after dis-
continuation of orthokeratology [44-46], it is unknown
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after cessation of ortho-k treatment [47] or whether a
rebound phenomenon will occur as reported in the at-
ropine study [48]. Further studies, including a longer
follow-up period after cessation of treatment are required
to answer these questions (especially in high myopia).
Third, only one ortho-k lens spherical design was used in
our study. There are a number of different lenses aimed at
controlling myopia in moderate to high astigmatic and
high myopic children [43], such as the toric reverse geom-
etry lens, which provides good lens centration on toric
corneas. Further investigation is warranted to address the
long-term safety and myopia control efficacy in these spe-
cially designed ortho-k lenses.
Conclusion
In conclusion, ortho-k contact lens wear is a promising
strategy for reducing myopic development in myopic
children. Elongation of axial length compared with sub-
jects wearing spectacles was slower by 49%, 59% and 46%
for low, moderate and high myopia during 2-year period.
Ortho-k treatment would be more beneficial to younger
myopic children. Early initiation of ortho-k treatment may
be possible to reduce the prevalence of high myopia.
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